Paper67185
An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems.
Bizzini B and 2 others. J Neurochem, 1977. Cited by 106 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems. Papers, record 67185. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/67185
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens | Major topic |
| Axonal Transport | Major topic |
| Gangliosides | Major topic |
| Peptides | Major topic |
| Tetanus Toxin | Major topic |
| Amino Acids | |
| Animals | |
| Chromatography, Affinity | |
| Chromatography, Gel | |
| Cross Reactions | |
| Electrophoresis, Polyacrylamide Gel | |
| Immunodiffusion | |
| In Vitro Techniques | |
| Isoelectric Focusing | |
| Molecular Weight | |
| Protein Binding | |
| Rats |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,662,508 | Discovery and engineering of the antibody response to a prominent skin commensal. | Nature | 2025 | https://conductscience.org/library/papers/39662508 | PubMed |
| 37,375,758 | Local Delivery Strategies for Peptides and Proteins into the CNS: Status Quo, Challenges, and Future Perspectives. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37375758 | PubMed |
| 36,668,863 | Anaerobes and Toxins, a Tradition of the Institut Pasteur. | Toxins (Basel) | 2023 | https://conductscience.org/library/papers/36668863 | PubMed |
| 36,668,838 | Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/36668838 | PubMed |
| 33,096,857 | Neurotrophic Properties of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Motor Neuron Disease. | Toxins (Basel) | 2020 | https://conductscience.org/library/papers/33096857 | PubMed |
| 32,456,061 | Axonal Transport as an In Vivo Biomarker for Retinal Neuropathy. | Cells | 2020 | https://conductscience.org/library/papers/32456061 | PubMed |
| 23,029,238 | Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging. | PLoS One | 2012 | https://conductscience.org/library/papers/23029238 | PubMed |
| 22,069,568 | Tetanus toxin C-fragment: the courier and the cure? | Toxins (Basel) | 2010 | https://conductscience.org/library/papers/22069568 | PubMed |
| 21,418,619 | Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule. | Orphanet J Rare Dis | 2011 | https://conductscience.org/library/papers/21418619 | PubMed |
| 21,124,874 | SV2 mediates entry of tetanus neurotoxin into central neurons. | PLoS Pathog | 2010 | https://conductscience.org/library/papers/21124874 | PubMed |
| 20,413,159 | Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding. | Mol Immunol | 2010 | https://conductscience.org/library/papers/20413159 | PubMed |
| 16,293,644 | Motor neurone targeting of IGF-1 prevents specific force decline in ageing mouse muscle. | J Physiol | 2006 | https://conductscience.org/library/papers/16293644 | PubMed |
| 10,727,419 | C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor. | Biochem J | 2000 | https://conductscience.org/library/papers/10727419 | PubMed |
| 10,212,474 | Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses. | Philos Trans R Soc Lond B Biol Sci | 1999 | https://conductscience.org/library/papers/10212474 | PubMed |
| 9,256,494 | Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9256494 | PubMed |
| 7,177,108 | A review of the molecular structure of tetanus toxin. | Mol Cell Biochem | 1982 | https://conductscience.org/library/papers/7177108 | PubMed |
| 6,205,994 | Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule. | Infect Immun | 1984 | https://conductscience.org/library/papers/6205994 | PubMed |
| 3,897,815 | Enzymatic hydrolysis of tetanus toxin by intrinsic and extrinsic proteases. Characterization of the fragments by monoclonal antibodies. | Med Microbiol Immunol | 1985 | https://conductscience.org/library/papers/3897815 | PubMed |
| 3,536,478 | Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. | EMBO J | 1986 | https://conductscience.org/library/papers/3536478 | PubMed |
| 3,301,392 | Relation between protective potency and specificity of antibodies in sera of tetanus immunized individuals. | Eur J Epidemiol | 1987 | https://conductscience.org/library/papers/3301392 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/67185
GET https://conductscience.org/api/papers/v1/67185/cited_by?page=2